Entero Healthcare Solutions Limited has informed the Exchange regarding Board meeting held on Jun 18, 2025.
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Entero Healthcare's board fixed its 7th Annual General Meeting for Thursday, September 18, 2025, at 11:30 AM via video conferencing. The remote e-voting window will run from September 15 to September 17, 2025, with September 11 set as the cut-off date for shareholder eligibility. Mr. Avinash Bagul of BNP & Associates was appointed as scrutinizer for the e-voting process. The board also approved an updated Fair Disclosure Code to align with recent SEBI Insider Trading amendments effective in 2024 and 2025. Additionally, 5,900 Employee Stock Options were granted under the existing Entero ESOP 2023 plan at an exercise price of INR 998 per option, with a vesting period of 1–4 years.
This is a routine administrative filing covering AGM logistics, a minor ESOP grant of 5,900 shares, and policy updates. The small size of the ESOP grant and the regulatory nature of the other items mean no material impact on shareholders or the stock price is expected.